Neuronetics, Inc. Amortization of Intangible Assets
Neuronetics, Inc. (STIM) reported Amortization of Intangible Assets of $400.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-11
- Neuronetics, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $400.00K, a 0.00% change year-over-year.
- Neuronetics, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $400.00K, a 0.00% change year-over-year.
- Neuronetics, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $400.00K, a 300.00% increase year-over-year.
- Neuronetics, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $400.00K.
- Neuronetics, Inc. amortization of intangible assets for fiscal 2025 was $1.50M, a 1400.00% increase from fiscal 2024.
- Neuronetics, Inc. amortization of intangible assets for fiscal 2024 was $100.00K.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $400.00K 10-Q · filed 2026-08-11 | $700.00K 10-Q · filed 2026-08-11 | $1.20M derived: sum of 3 quarters · filed 2026-08-11 | $1.60M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $400.00K 10-Q · filed 2026-05-05 | $800.00K derived: sum of 2 quarters · filed 2026-05-05 | $1.20M derived: sum of 3 quarters · filed 2026-05-05 | $1.60M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $800.00K derived: sum of 2 quarters · filed 2026-03-17 | $1.20M derived: sum of 3 quarters · filed 2026-08-11 | $1.50M 10-K · filed 2026-03-17 | ||
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-04 | $800.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.10M 10-Q · filed 2025-11-04 | $1.30M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-11 | $700.00K 10-Q · filed 2026-08-11 | $900.00K derived: sum of 3 quarters · filed 2026-08-11 | $900.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $400.00K 10-Q · filed 2025-05-06 | $500.00K derived: sum of 2 quarters · filed 2026-03-17 | $500.00K derived: sum of 3 quarters · filed 2026-03-17 | $500.00K derived: sum of 4 quarters · filed 2026-03-17 | ||
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $100.00K derived: sum of 2 quarters · filed 2026-03-17 | $100.00K derived: sum of 3 quarters · filed 2026-03-17 | $100.00K 10-K · filed 2026-03-17 | ||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-04 | $16.43K 8-K/A · filed 2025-02-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-04 | $0.00 10-Q · filed 2025-11-04 | $49.52K 8-K/A · filed 2025-02-06 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | |||||
| 2023-09-30 | $16.55K 8-K/A · filed 2025-02-06 | $49.64K 8-K/A · filed 2025-02-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |